Refine
Document Type
- Article (1)
- Part of Periodical (1)
Language
- English (2)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- Aphids (1)
- North Africa (1)
- Paediatrics (1)
- Stem-cell therapies (1)
- Western Asia (1)
- fauna (1)
- illustrated key (1)
- parasitoids (1)
Institute
- Medizin (1)
In this study, a total of 108 Aphidiinae species, belonging to 18 genera, associated with 240 aphid species in 16 countries of the Middle East and North Africa are reviewed. 743 host aphidparasitoid associations are listed. New material was collected from various regions of Saudi Arabia during 2011–2013. Three species including Aphidius avenae Haliday, 1834, Aphidius platensis Brèthes, 1913 and Praon barbatum Mackauer, 1967 are first recorded for the fauna of this country. Lysiphlebus marismortui Mescheloff & Rosen, 1990 syn. nov. is classified as the junior synonym of Lysiphlebus confusus Tremblay & Eady, 1978. An illustrated up-to-date key to all known species of Aphidiinae that occur in the Middle East and North Africa is provided. The findings are discussed in relation to the overall parasitoid-aphid associations in the target investigated region.
GATA2 deficiency is a heterogeneous multi-system disorder characterized by a high risk of developing myelodysplastic syndrome (MDS) and myeloid leukemia. We analyzed the outcome of 65 patients reported to the registry of the European Working Group (EWOG) of MDS in childhood carrying a germline GATA2 mutation (GATA2mut) who had undergone hematopoietic stem cell transplantation (HSCT). At 5 years the probability of overall survival and disease-free survival (DFS) was 75% and 70%, respectively. Non-relapse mortality and relapse equally contributed to treatment failure. There was no evidence of increased incidence of graft-versus-host-disease or excessive rates of infections or organ toxicities. Advanced disease and monosomy 7 (−7) were associated with worse outcome. Patients with refractory cytopenia of childhood (RCC) and normal karyotype showed an excellent outcome (DFS 90%) compared to RCC and −7 (DFS 67%). Comparing outcome of GATA2mut with GATA2wt patients, there was no difference in DFS in patients with RCC and normal karyotype. The same was true for patients with −7 across morphological subtypes. We demonstrate that HSCT outcome is independent of GATA2 germline mutations in pediatric MDS suggesting the application of standard MDS algorithms and protocols. Our data support considering HSCT early in the course of GATA2 deficiency in young individuals.